Neogen | NEOG - Selling And Administration Expenses


Neogen reported $98.5M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Agilent USD 465M 11M Mar/2026
Avanos Medical USD 77.7M 1.1M Mar/2026
Bio-Rad Laboratories USD 221M 14.2M Dec/2025
Cerus USD 19.33M 1.55M Dec/2024
Danaher USD 1.86B 166M Mar/2026
Idexx Laboratories USD 299.85M 24.18M Mar/2026
Illumina USD 272M 11M Mar/2026
Integra LifeSciences USD 178.24M 21.79M Mar/2026
Neogen USD 98.5M 9M Dec/2025
OraSure Technologies USD 13.21M 3.29M Dec/2025
Pacific Biosciences Of California USD 37.24M 25.68M Dec/2025
Quidel USD 199.3M 4.9M Mar/2026
Rockwell Medical USD 4.04M 330K Jun/2024
STAAR Surgical USD 38.64M 299K Mar/2026
Surmodics USD 11.4M 3.18M Jun/2025
Thermo Fisher Scientific USD 1.8B 179M Mar/2026
Utah Medical Products USD 2.61M 741K Dec/2025
Zoetis USD 588M 31M Mar/2026